Elion Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Elion Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy (NCT07215273) | Elion Therapeutics, Inc. | 2026-02-13 |
Track Elion Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.